Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3366949 | Joint Bone Spine | 2008 | 4 Pages |
Abstract
Spondyloarthropathies are associated with a greater cardiovascular risk than expected based on the cardiac lesions known to occur in these diseases. The prevalence of several conventional risk factors is high in spondyloarthropathy patients, and chronic inflammation also contributes to premature plaque formation. In addition, susceptibility genes for spondyloarthropathies may be associated with an increased risk of cardiovascular disease. Finally, several drugs used to treat spondyloarthropathies may contribute to the occurrence of cardiovascular events. A careful evaluation of the cardiovascular risk profile is a key component of the management of patients with spondyloarthropathies.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Ulric Vinsonneau, Aurore Brondex, Jacques Mansourati, Alain Saraux, Jean Christophe Cornily, Florence Arlès, Patrick Godon, Gilles Quiniou,